Recent News

By Category: Biosafety

Giant virus on ice for 30,000 years could signal danger

(Whitsunday Times) THE discovery of an infectious giant virus that had been entombed in Siberian permafrost for 30,000 years has led scientists to warn of other disease-causing viruses and microbes that may escape from the frozen earth once it has melted. Scientists in France and Russia discovered the virus in samples of frozen earth taken  Read More »

Obama Seeks ‘Final’ Funds to Build Kansas Biodefense Site

(Global Security News Wire) The Obama administration this week asked Congress for a $300 million “final” appropriation to construct a new biodefense laboratory in Kansas.The money is the last that officials would need to finish building the National Bio and Agro-Defense Facility in Manhattan, Kan., the U.S. Homeland Security Department said in its budget request  Read More »

Incorporating Antimicrobial Polymers to Protect Warfighters

(Global Biodefense) A multi-institution team, managed by DTRA CB’s Dr. Brian Pate and including David Whitten and other inventors from the University of New Mexico, University of Florida, Duke University, and the U.S. Army Natick Soldier Research, Development & Engineering Center (NSRDEC), was issued a patent on materials incorporating antimicrobial polymers. In the patent application,  Read More »

Biosecurity vital in combating swine virus in N.D.

(Farm and Ranch) Implementing strict biosecurity procedures is as important as ever, now that North Dakota has its first case of the porcine epidemic diarrhea virus (PEDv), North Dakota State University Extension Service swine specialist David Newman says. The PEDv has killed more than 4 million U.S. pigs since it was discovered in the country  Read More »

Pharma refuses to ensure access to lifesaving Hepatitis C treatment at global meeting

(Medical News Today) Thirty-eight activists from 22 countries joined forces at the first-ever Hepatitis C Virus (HCV) World Community Advisory Board (CAB) to demand equitable access to treatment for hepatitis C virus (HCV) from six multinational pharmaceutical companies. Yet AbbVie, Bristol-Myers Squibb, Gilead, Janssen, Merck, and Roche refused to provide a plan for equitable access  Read More »

« First...1213141516...203040...Last »

Also filed under "Biosafety":